Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $672.98 | 46 | 90.7% |
| Education | $69.22 | 3 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $500.53 | 43 | $0 (2021) |
| Secura Bio, Inc. | $141.47 | 1 | $0 (2019) |
| LEO Pharma Inc. | $30.00 | 1 | $0 (2018) |
| Lilly USA, LLC | $27.87 | 1 | $0 (2022) |
| Amgen Inc. | $26.39 | 2 | $0 (2022) |
| GlaxoSmithKline, LLC. | $15.94 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $41.88 | 2 | Lilly USA, LLC ($27.87) |
| 2021 | $11.63 | 1 | Novo Nordisk Inc ($11.63) |
| 2020 | $112.86 | 8 | Novo Nordisk Inc ($112.86) |
| 2019 | $268.01 | 13 | Secura Bio, Inc. ($141.47) |
| 2018 | $170.41 | 13 | Novo Nordisk Inc ($124.47) |
| 2017 | $137.41 | 12 | Novo Nordisk Inc ($125.03) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/07/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiology | ||||||
| 08/04/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Diabetes | ||||||
| 07/15/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Diabetes | ||||||
| 11/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Diabetes | ||||||
| 10/05/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 09/15/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Diabetes | ||||||
| 08/19/2020 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 08/18/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Diabetes | ||||||
| 07/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Diabetes | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Diabetes | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Diabetes | ||||||
| 12/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Diabetes | ||||||
| 12/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: Diabetes | ||||||
| 11/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Diabetes | ||||||
| 10/08/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Diabetes | ||||||
| 08/26/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Diabetes | ||||||
| 07/23/2019 | Secura Bio, Inc. | FARYDAK (Drug), FARYDAK, FARYDAK | Food and Beverage | Cash or cash equivalent | $141.47 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.45 | General |
| Category: Diabetes | ||||||
| 06/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Diabetes | ||||||
| 04/25/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Diabetes | ||||||
| 04/04/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Diabetes | ||||||
| 03/07/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diabetes | ||||||
| 02/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: Diabetes | ||||||
| 01/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Diabetes | ||||||
| 12/12/2018 | LEO Pharma Inc. | — | Education | In-kind items and services | $30.00 | General |
About Dr. Mitchell Becker, M.D
Dr. Mitchell Becker, M.D is a Internal Medicine healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922033935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Becker, M.D has received a total of $742.20 in payments from pharmaceutical and medical device companies, with $41.88 received in 2022. These payments were reported across 49 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($672.98).
Practice Information
- Specialty Internal Medicine
- Location Santa Monica, CA
- Active Since 07/11/2006
- Last Updated 12/10/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922033935
Products in Payments
- Ozempic (Drug) $346.69
- Victoza (Drug) $153.84
- FARYDAK (Drug) $141.47
- MOUNJARO (Drug) $27.87
- SHINGRIX (Biological) $15.94
- Repatha (Biological) $14.01
- Prolia (Biological) $12.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Santa Monica
Dr. Przemyslaw Twardowski, Md, MD
Internal Medicine — Payments: $1.2M
Richard Finn, Md, MD
Internal Medicine — Payments: $1.1M
Saeed Sadeghi, Md, MD
Internal Medicine — Payments: $809,489
Zev Wainberg, Md, MD
Internal Medicine — Payments: $745,774
Dr. Stephen Kania, M.d, M.D
Internal Medicine — Payments: $707,242
Dr. Jonathan Goldman, M.d, M.D
Internal Medicine — Payments: $264,528